A data review is available in the Ten-year Review of Global Endometrial Ablation with the NovaSure Device. This article examines the peer-reviewed literature describing prospective studies that report amenorrhea rates, patient satisfaction and surgical reintervention rates following the NovaSure endometrial ablation procedure.
Methodology: Ten prospective studies, six single-arm NovaSure trials and four randomized controlled trials were reviewed for amenorrhea rate, success rate, reintervention rate and patient satisfaction. The follow-up period for these measures was 6-60 months.
Long-standing, extensive prospective clinical data clearly demonstrate that the NovaSure endometrial ablation system is a global leader, delivering outstanding results2:
Review the data ### Results demonstrated at 5 year follow-up
A study by Gallinat A. et al. was conducted to assess the safety, efficacy and data durability of the NovaSure endometrial ablation system five years after the procedure was conducted in women with severe menorrhagia secondary to dysfunctional uterine bleeding (DUB). Long-term clinical results indicate that the NovaSure system is a safe and effective method for treatment of women with menorrhagia secondary to DUB, yielding high amenorrhea and success rates and low surgical reintervention rates five years after treatment.
*At 5 years, follow-up data available for 103/107 patients
From its bi-polar radiofrequency (RF) energy to a single scientific endpoint, every aspect of the NovaSure procedure has been designed to deliver exceptional results. Here’s how it works.
Four uniquely designed electrodes that form the array deliver the bi-polar RF energy, a proven ablation modality in many surgical specialties. The array shape is designed to deliver the proper depth of energy, while the ablation profile is designed to be tapered to the uterine cavity.
Our patented technology allows you to perform a proactive cavity assessment, ensuring that the cavity can hold 50 mmHg to check for a perforation. The assessment is sensitive enough to detect a perforation as small as an 18-gauge needle.
With its moisture transport fluid removal system, the vacuum draws uterine cavities into contact with the array—including some that are imperfectly shaped. It also removes steam, moisture and other by-products during the ablation.
50 ohms of impedance determines when the ablation is complete. Average treatment time is just 90 seconds1—and ablation is never more than 2 minutes.
* Individual Results May Vary
David J Patton, M.D. – Charleston, Beckley & Madison offices
Molly Steele, FNP – Charleston, Beckley & Madison offices
Katie Boggs, FNP-BC. – Beckley
Deanna Farmer, CNM – Charleston & Beckley offices
Tara Robinson, P.A.-C -Charleston & Beckley offices